Collegium Pharmaceutical
COLL
COLL
120 hedge funds and large institutions have $580M invested in Collegium Pharmaceutical in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 48 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
120
Holders Change
-4
Holders Change %
-3.23%
% of All Funds
2.68%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
16
Increased
40
Reduced
48
Closed
19
Calls
$1.2M
Puts
$319K
Net Calls
+$876K
Net Calls Change
-$4.3M
Top Buyers
| 1 |
Millennium Management
New York
|
+$20.1M |
| 2 |
PA
Perceptive Advisors
New York
|
+$7.37M |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$6.29M |
| 4 |
UBS AM
Chicago,
Illinois
|
+$5.03M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$3.81M |
Top Sellers
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$14.3M |
| 2 |
JGC
J. Goldman & Co
New York
|
-$8.84M |
| 3 |
Morgan Stanley
New York
|
-$8.19M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
-$6.22M |
| 5 |
Two Sigma Investments
New York
|
-$3.37M |
